Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
P. Olander Medica development AB
AB
Active
Org 5592354301
Sparsörsvägen 1, 513 50
Sparsör
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2020 · 6 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
P. Olander Medica development AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: not reported
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
—
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−441
−50
−189
−168
−453
Depreciation & amort.
—
−0
−0
−0
−0
EBIT
−441
−50
−189
−168
−453
Net financials
−16
—
—
—
—
Profit before tax
−28
1
0
0
0
Tax
—
−6
−0
−0
−0
Net profit
−28
−5
0
0
0
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
33 969
21 739
15 218
10 087
8 388
Equity
5 119
44
49
49
49
Long-term debt
23 571
20 681
14 055
9 410
7 085
Short-term debt
5 279
1 014
1 114
627
1 254
Total debt
28 850
21 695
15 169
10 037
8 339
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2021
2025
Equity ratio
15,1 %
This company
38,2 %
Market median
This company
Market median
60% below market
2021
2025
Return on equity
−0,5 %
This company
18,4 %
Market median
This company
Market median
103% below market
2021
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2021
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2021
2025
Debt / equity
5,64×
This company
0,62×
Market median
This company
Market median
810% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on P. Olander Medica development AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
